Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v4-FR Version v3-EN
Language French English
Date Updated 2021-07-16 2021-07-16
Drug Identification Number 02213834 02213834
Brand name NASACORT AQ NASACORT AQ
Common or Proper name Triamcinolone acetonide spray Triamcinolone acetonide spray
Company Name SANOFI CONSUMER HEALTH INC SANOFI CONSUMER HEALTH INC
Ingredients TRIAMCINOLONE ACETONIDE TRIAMCINOLONE ACETONIDE
Strength(s) 55MCG 55MCG
Dosage form(s) SPRAY, METERED DOSE SPRAY, METERED DOSE
Route of administration NASAL NASAL NASAL NASAL
Packaging size Bottle Bottle
ATC code R01AD R01AD
ATC description DECONGESTANTS AND OTHER NASAL PREP.FOR TOPICAL USE DECONGESTANTS AND OTHER NASAL PREP.FOR TOPICAL USE
Reason for shortage Delay in shipping of the drug. Delay in shipping of the drug.
Anticipated start date
Actual start date 2021-06-30 2021-06-30
Estimated end date 2021-08-12 2021-08-12
Actual end date 2021-07-15 2021-07-15
Shortage status Resolved Resolved
Tier 3 Status No No
Company comments Transportation delay - The availability date represents estimated availability at the main Sanofi warehouse. Availability dates at a customer’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date. Transportation delay - The availability date represents estimated availability at the main Sanofi warehouse. Availability dates at a customer’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date.
Health Canada comments